IllumiNeuro Blend 48mg – PE-22-28 10mg + Pinealon 10mg + N-Acetyl Semax 20mg + N-Acetyl Selank 8mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of IGF-1 LR3 supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF092025032

Key analytical results include:

• Assay Content: 1.076 mg
• Identification – Retention Time: 0.990
• Identification – Spectrum: 984
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

IGF-1 LR3 is a synthetic analogue of insulin-like growth factor-1 frequently studied in controlled laboratory environments investigating cellular growth signalling and receptor-mediated biological pathways.

The compound belongs to a class of recombinant peptide growth factors that interact with insulin-like growth factor receptors involved in cellular signalling and metabolic regulatory systems.

This preparation contains 1 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, IGF-1 LR3 has become a widely referenced molecule in experimental models studying cellular growth signalling and receptor-mediated biochemical pathways.

Compound Overview

IGF-1 LR3, or insulin-like growth factor-1 long arginine-3, is a synthetic analogue derived from naturally occurring IGF-1.

The peptide has been structurally modified to extend its stability and receptor interaction properties in laboratory research models.

In experimental biochemical studies, IGF-1 LR3 is frequently examined for its interaction with insulin-like growth factor receptors (IGF receptors) involved in cellular signalling and metabolic regulation.

These receptor-mediated pathways are involved in complex intracellular signalling networks that regulate cellular growth processes and metabolic communication systems.

Historical Background and Scientific Context

Interest in insulin-like growth factor signalling systems expanded significantly during the late twentieth century as molecular biology techniques advanced.

Researchers investigating endocrine signalling and cellular growth pathways identified IGF-1 as a key signalling molecule involved in metabolic regulation and cellular communication.

To further explore these pathways, modified analogues such as IGF-1 LR3 were developed to study receptor binding behaviour and signalling dynamics under controlled experimental conditions.

Since its development, IGF-1 LR3 has been widely utilised in biochemical research examining receptor-mediated signalling networks and intracellular regulatory pathways.

Mechanistic Focus in Research

Within experimental laboratory environments, IGF-1 LR3 is commonly studied in relation to receptor-mediated signalling pathways and cellular regulatory mechanisms.

Research investigations often explore the compound in experimental models examining:

• IGF receptor signalling dynamics
• Cellular growth signalling pathways
• Intracellular metabolic signalling networks
• Peptide-receptor interaction mechanisms
• Comparative growth factor signalling studies
• Cellular regulatory pathway modelling
• Receptor-mediated biochemical processes

These experimental models allow scientists to investigate molecular signalling systems that influence cellular communication and metabolic regulatory networks.

Research Applications

In controlled research environments, IGF-1 LR3 may be utilised in experimental models designed to explore cellular growth signalling and receptor-mediated biological systems.

Examples of research applications include:

• Cell signalling pathway investigation
• Growth factor receptor research
• Intracellular signalling network analysis
• Peptide-receptor interaction studies
• Comparative biochemical compound evaluation
• Cellular regulatory pathway modelling
• Controlled in vitro receptor signalling studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Verified and analysed with Liquilabs s.r.o. (Czechia)
High-purity multi-peptide neuroresearch blend
Validated assay content of four analytically verified peptides
Retention time identification and full COA traceability
Endotoxin levels below 0.001 EU per mg
No detectable heavy metals or microbial growth
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.